{"id":"W3000263047","doi":"10.1016/j.jacl.2020.01.001","title":"Efficacy and safety of alirocumab in statin-intolerant patients over 3 years: open-label treatment period of the ODYSSEY ALTERNATIVE trial","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Statin; Online transaction processing; Internal medicine; Ezetimibe; Atorvastatin; Cholesterol; Lipoprotein; Database","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001413579,0.0001106349,0.001401472,0.00004288853,0.00001738414,0.000005592349,0.0001979468,0.0001240176,0.0000466544],"category_scores_gemma":[0.002062274,0.00006341007,0.000285537,0.000114983,0.0001666731,0.00005468719,0.0001282554,0.000371223,8.938145e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004638762,"about_ca_system_score_gemma":0.000435252,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001450074,"about_ca_topic_score_gemma":0.00002160471,"domain_scores_codex":[0.9967045,0.000773041,0.001827393,0.0001744027,0.000379277,0.000141346],"domain_scores_gemma":[0.9978452,0.0004938877,0.001082617,0.0002227899,0.0001778432,0.0001776053],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.489867,0.01123648,0.1656323,0.0002448045,0.0026857,0.00008246394,0.005908914,0.00005034959,0.0003203226,0.0003305654,0.0009933892,0.3226478],"study_design_scores_gemma":[0.3705552,0.02772815,0.5913806,0.0002524652,0.000322535,0.00002875744,0.0001341641,0.00008707515,0.0001258612,0.00007866331,0.009226039,0.00008048188],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954628,0.0002339376,0.00003035794,0.00226441,0.0009753102,0.0009171767,0.00001679717,0.000001257629,0.00009794412],"genre_scores_gemma":[0.9966101,0.0006436225,0.0005982898,0.0008022903,0.001314614,0.000003608727,0.000001954992,0.00001111533,0.00001441828],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4257483,"threshold_uncertainty_score":0.2585787,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1230577307056659,"score_gpt":0.4261600842721358,"score_spread":0.3031023535664699,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}